Shareholders Equity: The sum of preferred and common equity items.
Ono Pharmaceutical Co. (OPHLF) had Shareholders Equity of $5.49B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.82B |
|
$661.06M |
|
$4.23B |
|
$7.05B |
|
$931.22M |
|
$536.25M |
|
$622.54M |
|
$1.55B |
|
$5.49B |
|
$2.95B |
|
|
Shareholders Equity |
$5.49B |
469.91M |
|
| Cash Flow Statement Financials | |
$563.15M |
|
$-286.31M |
|
$-388.89M |
|
$1.33B |
|
$1.22B |
|
$-105.18M |
|
-- |
|
$-236.84M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|